Skip to main content English

Detail

Teresa Binter
Dr. med. univ. Teresa Binter

Department of General Surgery (Division of Visceral Surgery)
Position: Doctor-in-training

ORCID: 0000-0002-9930-2767
teresa.binter@meduniwien.ac.at

Further Information

Keywords

Hyperparathyroidism; Multiple Endocrine Neoplasia; Neuroendocrine Tumors; Thyroid Gland

Selected publications

  1. Binter, T. et al. (2024) ‘Does Genotype-Specific Phenotype in Patients with Multiple Endocrine Neoplasia Type 2 Occur as Current Guidelines Predict?’, Cancers, 16(3), p. 494. Available at: https://doi.org/10.3390/cancers16030494.
  2. Arikan, M. et al. (2023) ‘Feasibility of Autofluorescence Using Overlay Imaging for the Detection of Parathyroid Glands: Defining Standards’, Annals of Surgical Oncology, 31(2), pp. 1116–1124. Available at: https://doi.org/10.1245/s10434-023-14552-7.
  3. Semmler, G. et al. (2021) ‘Influence of Genetic Variants on Disease Regression and Outcomes in HCV-Related Advanced Chronic Liver Disease after SVR’, Journal of Personalized Medicine, 11(4), p. 281. Available at: https://doi.org/10.3390/jpm11040281.
  4. Jachs, M. et al. (2021) ‘Outcomes of an HCV elimination program targeting the Viennese MSM population’, Wiener klinische Wochenschrift, 133(13–14), pp. 635–640. Available at: https://doi.org/10.1007/s00508-021-01898-9.
  5. Semmler, G. et al. (2021) ‘Noninvasive Risk Stratification After HCV Eradication in Patients With Advanced Chronic Liver Disease’, Hepatology, 73(4), pp. 1275–1289. Available at: https://doi.org/10.1002/hep.31462.